Rosalind Advisors, Inc.
13F filer · CIK 1622627 · Toronto
Summary
Rosalind Advisors, Inc. reported $269.20M across 35 positions in its 13F for 2026 Q2, filed Aug 14, 2026. The largest holdings are DCTH (15.4%), FENC (12.7%), XERS (8.6%). Versus 2026 Q1, leaving options aside, it opened 3 new positions, added to 7, trimmed 11 and sold out of 6.
Reported value$269.20M
Positions35incl. options
Report period2026 Q2
FiledAug 14, 2026
New positions3
Added7
Trimmed11
Sold out6
Top 25 holdings
By reported value, options listed separately · change vs 2026 Q1
Weight 15.4%Value $41.55MPrice $15.81Shares 3.30MSince Jun 30 +25.58%
Weight 12.7%Value $34.27MPrice $10.95Shares 3.19M +9.62%Since Jun 30 +1.86%
Weight 8.6%Value $23.04MPrice $9.83Shares 2.91M -9.99%Since Jun 30 +24.12%
Weight 7.3%Value $19.58MPrice $5.07Shares 3.18M -0.80%Since Jun 30 -17.69%
Weight 5.7%Value $15.23MPrice $7.77Shares 3.99M +86.42%Since Jun 30 +103.40%
Weight 5.6%Value $15.01MPrice $3.02Shares 3.21MSince Jun 30 -35.44%
Weight 5.2%Value $14.13MPrice $3.31Shares 988K -4.68%Since Jun 30 -76.85%
Weight 4.8%Value $12.93MPrice $12.59Shares 1.96M +27.74%Since Jun 30 +90.47%
Weight 4.4%Value $11.94MPrice $18.31Shares 649K -7.34%Since Jun 30 -0.54%
Weight 4.3%Value $11.63MPrice $58.27Shares 200K -31.03%Since Jun 30 +0.24%
Weight 4.1%Value $11.01MPrice $13.93Shares 749KSince Jun 30 -5.24%
Weight 2.8%Value $7.44MPrice $31.64Shares 200K -39.39%Since Jun 30 -14.97%
Weight 2.7%Value $7.22MPrice $8.27Shares 722K -21.84%Since Jun 30 -17.30%
Weight 2.0%Value $5.51MPrice $5.92Shares 828KSince Jun 30 -10.98%
Weight 2.0%Value $5.32MPrice $1.19Shares 5.17M +54.13%Since Jun 30 +15.53%
Weight 1.8%Value $4.98MPrice $5.18Shares 1.07M -8.64%Since Jun 30 +11.40%
Weight 1.4%Value $3.78MPrice $1.56Shares 3.64M -5.44%Since Jun 30 +50.00%
Weight 1.1%Value $2.98MPrice $2.46Shares 1.11MSince Jun 30 -8.55%
Weight 1.1%Value $2.97MPrice $7.40Shares 508K +77.56%Since Jun 30 +26.54%
Weight 1.0%Value $2.78MPrice $98.50Shares 21KSince Jun 30 -26.08%
Weight 1.0%Value $2.73MPrice $0.69Shares 3.91MSince Jun 30 -1.51%
Weight 0.9%Value $2.48MPrice $1.89Shares 702K +178.99%Since Jun 30 -46.46%
Weight 0.7%Value $1.98MPrice $5.31Shares 389K -34.87%Since Jun 30 +4.53%
Weight 0.4%Value $1.21MPrice $1.09Shares 1.28M +9.59%Since Jun 30 +15.28%
Weight 0.4%Value $1.10MPrice $10.61Shares 100KSince Jun 30 -3.28%
| Stock | Weight | Value | Since Jun 30 | Shares change | Action |
|---|---|---|---|---|---|
| 15.4% | $41.55M | +25.58% | — | Hold | |
| 12.7% | $34.27M | +1.86% | +9.62% | Add | |
| 8.6% | $23.04M | +24.12% | -9.99% | Trim | |
| 7.3% | $19.58M | -17.69% | -0.80% | Trim | |
| 5.7% | $15.23M | +103.40% | +86.42% | Add | |
| 5.6% | $15.01M | -35.44% | — | Hold | |
| 5.2% | $14.13M | -76.85% | -4.68% | Trim | |
| 4.8% | $12.93M | +90.47% | +27.74% | Add | |
| 4.4% | $11.94M | -0.54% | -7.34% | Trim | |
| 4.3% | $11.63M | +0.24% | -31.03% | Trim | |
| 4.1% | $11.01M | -5.24% | — | Hold | |
| 2.8% | $7.44M | -14.97% | -39.39% | Trim | |
| 2.7% | $7.22M | -17.30% | -21.84% | Trim | |
| 2.0% | $5.51M | -10.98% | — | Hold | |
| 2.0% | $5.32M | +15.53% | +54.13% | Add | |
| 1.8% | $4.98M | +11.40% | -8.64% | Trim | |
| 1.4% | $3.78M | +50.00% | -5.44% | Trim | |
| 1.1% | $2.98M | -8.55% | — | Hold | |
| 1.1% | $2.97M | +26.54% | +77.56% | Add | |
| 1.0% | $2.78M | -26.08% | — | New | |
| 1.0% | $2.73M | -1.51% | — | Hold | |
| 0.9% | $2.48M | -46.46% | +178.99% | Add | |
| 0.7% | $1.98M | +4.53% | -34.87% | Trim | |
| 0.4% | $1.21M | +15.28% | +9.59% | Add | |
| 0.4% | $1.10M | -3.28% | — | Hold |
Weight is the share of the reported 13F value, including options at notional value. “Since Jun 30” compares the latest close with the quarter-end price implied by the filing (value ÷ shares).
Largest buys in 2026 Q2
Largest sells in 2026 Q2
Options
Notional value, listed apart from stocks
SELLAS LIFE SCIENCES GROUP INCNo ticker matchPUT$2.30MNew
CG ONCOLOGY INCNo ticker matchCALL$375.1KNew
EYEPOINT PHARMACEUTICALS INCNo ticker matchCALL$130.8KNew
ISHARES TRNo ticker matchPUT$110.0KNew
SPDR SERIES TRUSTNo ticker matchPUT$35.1KNew
TENAX THERAPEUTICS INCNo ticker matchPUT$13.9KNew
Source: SEC Form 13F, values as reported by the filer. Filings lag up to 45 days after quarter end and cover only certain long positions. Research only, not investment advice.